Skip to content

Evaluation of the effect of fractional carbon dioxide laser with platelet-rich plasma in the treatment of burn scars

Evaluation of efficacy, satisfaction, and complication of fractional carbon dioxide laser treatment with platelet-rich plasma in comparison with fractional carbon dioxide laser alone in the treatment of burn scars

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210515051307N2
Enrollment
20
Registered
2021-12-26
Start date
2021-12-11
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn scar. Scar conditions and fibrosis of skin

Interventions

Sponsors

Skin and Stem cellResearch Center of Tehran University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with skin type 1-4 Patients with atrophic burn scars in more than one limb, from five years ago to the last 3 months

Exclusion criteria

Exclusion criteria: Age under 18 years. Patients who have received laser treatment in the last three months Patients with active colloidal scar or active skin lesion at the injection site Patients with coagulation and platelet disorders Patients with a history of taking anticoagulants Patients with a history of underlying diseases such as diabetes and autoimmune connective tissue disease that affect the wound healing process Patients with active viral infections History of malignancy or receiving chemotherapy Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
The effectiveness of treatment. Timepoint: Before starting the trial, and two months after the last session of treatment. Method of measurement: Photography and biometry of the burn scars will be done. The scoring of the scars will be performed based on the Vancouver scoring system.;Patient satisfaction from treatment. Timepoint: In the second and third sessions of treatment with laser and two months after the last session. Method of measurement: Patient global assessment score.;Physician satisfaction from treatment. Timepoint: In the second and third sessions of treatment with laser and two months after the last session. Method of measurement: Physician global assessment score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoomeh Rohaninasab

Iran University of Medical Sciences

Masoomehrohani@yahoo.com+98 21 6435 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026